Northwestern Medicine scientists are diving deep into the structure and function of ion channels to inform new therapies.
Kelly Michelson, MD, MPH, ’04 GME, applies her clinical experience to research and education as the director of Northwestern’s Center for Bioethics and Medical Humanities.
Revolutionary nanomaterials developed at Northwestern could make it possible to repair tissues and organs spanning from bone and cartilage to muscle and brain tissues.
A passion for senior care brought Lee Lindquist, ’00 MD, ’03 ’05 GME, ’05 MPH, ’10 MBA, to Northwestern as a first-year medical student in 1996 and has kept her here for two decades.
Northwestern’s Cancer Survivorship Institute addresses the medical, psychological and social challenges patients face after their cancer is gone.
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
Northwestern Medicine scientists are exploring a new drug that could make people healthier for longer by slowing the aging process.
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.
This year, the University launched a new Center for Synthetic Biology, making Northwestern one of the top three U.S. destinations for research and education in this area.
Northwestern Medicine scientists take innovative cell-based approaches to induce immune tolerance In kidney transplant recipients.